Similar articles for PMID: 23443925

Year	Number of Results
2006	4
2007	1
2008	4
2009	4
2010	3
2011	5
2012	6
2013	10
2014	10
2015	6
2016	13
2017	14
2018	12
2019	7
2020	5
2021	4
2022	4
2023	5
2024	1

1

FGF23 is a novel regulator of intracellular calcium and cardiac contractility in addition to cardiac hypertrophy.

Touchberry CD, Green TM, Tchikrizov V, Mannix JE, Mao TF, Carney BW, Girgis M, Vincent RJ, Wetmore LA, Dawn B, Bonewald LF, Stubbs JR, Wacker MJ. Touchberry CD, et al. Am J Physiol Endocrinol Metab. 2013 Apr 15;304(8):E863-73. doi: 10.1152/ajpendo.00596.2012. Epub 2013 Feb 26. Am J Physiol Endocrinol Metab. 2013. PMID: 23443925 Free PMC article.

2

Fibroblast growth factor 23 (FGF23) induces ventricular arrhythmias and prolongs QTc interval in mice in an FGF receptor 4-dependent manner.

Graves JM, Vallejo JA, Hamill CS, Wang D, Ahuja R, Patel S, Faul C, Wacker MJ. Graves JM, et al. Am J Physiol Heart Circ Physiol. 2021 Jun 1;320(6):H2283-H2294. doi: 10.1152/ajpheart.00798.2020. Epub 2021 Apr 30. Am J Physiol Heart Circ Physiol. 2021. PMID: 33929896 Free PMC article.

3

Crosstalk between FGF23- and angiotensin II-mediated Ca²⁺ signaling in pathological cardiac hypertrophy.

Mhatre KN, Wakula P, Klein O, Bisping E, Völkl J, Pieske B, Heinzel FR. Mhatre KN, et al. Cell Mol Life Sci. 2018 Dec;75(23):4403-4416. doi: 10.1007/s00018-018-2885-x. Epub 2018 Jul 30. Cell Mol Life Sci. 2018. PMID: 30062428

4

Fibroblast growth factor 23 does not directly influence skeletal muscle cell proliferation and differentiation or ex vivo muscle contractility.

Avin KG, Vallejo JA, Chen NX, Wang K, Touchberry CD, Brotto M, Dallas SL, Moe SM, Wacker MJ. Avin KG, et al. Am J Physiol Endocrinol Metab. 2018 Oct 1;315(4):E594-E604. doi: 10.1152/ajpendo.00343.2017. Epub 2018 Mar 20. Am J Physiol Endocrinol Metab. 2018. PMID: 29558205 Free PMC article.

5

Dietary phosphate restriction suppresses phosphaturia but does not prevent FGF23 elevation in a mouse model of chronic kidney disease.

Zhang S, Gillihan R, He N, Fields T, Liu S, Green T, Stubbs JR. Zhang S, et al. Kidney Int. 2013 Oct;84(4):713-21. doi: 10.1038/ki.2013.194. Epub 2013 May 22. Kidney Int. 2013. PMID: 23698235 Free PMC article.

6

Soluble α-klotho and heparin modulate the pathologic cardiac actions of fibroblast growth factor 23 in chronic kidney disease.

Yanucil C, Kentrup D, Campos I, Czaya B, Heitman K, Westbrook D, Osis G, Grabner A, Wende AR, Vallejo J, Wacker MJ, Navarro-Garcia JA, Ruiz-Hurtado G, Zhang F, Song Y, Linhardt RJ, White K, Kapiloff MS, Faul C. Yanucil C, et al. Kidney Int. 2022 Aug;102(2):261-279. doi: 10.1016/j.kint.2022.03.028. Epub 2022 May 2. Kidney Int. 2022. PMID: 35513125 Free PMC article.

7

FGF23 induces left ventricular hypertrophy.

Faul C, Amaral AP, Oskouei B, Hu MC, Sloan A, Isakova T, Gutiérrez OM, Aguillon-Prada R, Lincoln J, Hare JM, Mundel P, Morales A, Scialla J, Fischer M, Soliman EZ, Chen J, Go AS, Rosas SE, Nessel L, Townsend RR, Feldman HI, St John Sutton M, Ojo A, Gadegbeku C, Di Marco GS, Reuter S, Kentrup D, Tiemann K, Brand M, Hill JA, Moe OW, Kuro-O M, Kusek JW, Keane MG, Wolf M. Faul C, et al. J Clin Invest. 2011 Nov;121(11):4393-408. doi: 10.1172/JCI46122. Epub 2011 Oct 10. J Clin Invest. 2011. PMID: 21985788 Free PMC article.

8

FGF23 directly impairs endothelium-dependent vasorelaxation by increasing superoxide levels and reducing nitric oxide bioavailability.

Silswal N, Touchberry CD, Daniel DR, McCarthy DL, Zhang S, Andresen J, Stubbs JR, Wacker MJ. Silswal N, et al. Am J Physiol Endocrinol Metab. 2014 Sep 1;307(5):E426-36. doi: 10.1152/ajpendo.00264.2014. Epub 2014 Jul 22. Am J Physiol Endocrinol Metab. 2014. PMID: 25053401 Free PMC article.

9

FGF23 regulates renal sodium handling and blood pressure.

Andrukhova O, Slavic S, Smorodchenko A, Zeitz U, Shalhoub V, Lanske B, Pohl EE, Erben RG. Andrukhova O, et al. EMBO Mol Med. 2014 Jun;6(6):744-59. doi: 10.1002/emmm.201303716. Epub 2014 Apr 6. EMBO Mol Med. 2014. PMID: 24797667 Free PMC article.

10

FGF23 induced left ventricular hypertrophy mediated by FGFR4 signaling in the myocardium is attenuated by soluble Klotho in mice.

Han X, Cai C, Xiao Z, Quarles LD. Han X, et al. J Mol Cell Cardiol. 2020 Jan;138:66-74. doi: 10.1016/j.yjmcc.2019.11.149. Epub 2019 Nov 21. J Mol Cell Cardiol. 2020. PMID: 31758962 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year